Calamos Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24,774
Closed -$9.14M 927
2024
Q4
$9.14M Buy
24,774
+131
+0.5% +$54.8K 0.04% 418
2024
Q3
$12.8M Buy
24,643
+299
+1% +$160K 0.06% 354
2024
Q2
$13.2M Buy
24,344
+184
+0.8% +$97.3K 0.06% 341
2024
Q1
$12.5M Buy
24,160
+132
+0.5% +$65.6K 0.06% 345
2023
Q4
$11.3M Buy
24,028
+156
+0.7% +$72.1K 0.06% 360
2023
Q3
$10.4M Buy
23,872
+146
+0.6% +$66.2K 0.06% 383
2023
Q2
$10.5M Buy
23,726
+72
+0.3% +$33.2K 0.05% 404
2023
Q1
$10.9M Buy
23,654
+57
+0.2% +$27.1K 0.05% 410
2022
Q4
$12.1M Buy
23,597
+96
+0.4% +$48.7K 0.06% 412
2022
Q3
$10.7M Sell
23,501
-18,704
-44% -$8.95M 0.05% 449
2022
Q2
$20.4M Buy
42,205
+16,315
+63% +$8.07M 0.09% 256
2022
Q1
$12.7M Buy
25,890
+7,020
+37% +$3.21M 0.05% 444
2021
Q4
$8.75M Hold
18,870
0.04% 540
2021
Q3
$7.04M Hold
18,870
0.03% 521
2021
Q2
$7.21M Hold
18,870
0.04% 487
2021
Q1
$6.77M Hold
18,870
0.04% 445
2020
Q4
$6.06M Hold
18,870
0.04% 455
2020
Q3
$5.07M Sell
18,870
-1,248
-6% -$336K 0.04% 459
2020
Q2
$5.29M Sell
20,118
-415
-2% -$111K 0.04% 435
2020
Q1
$4.66M Sell
20,533
-63,740
-76% -$17.4M 0.04% 409
2019
Q4
$25.5M Sell
84,273
-33
-0% -$9.08K 0.14% 205
2019
Q3
$20.2M Sell
84,306
-427
-0.5% -$117K 0.12% 235
2019
Q2
$23.9M Sell
84,733
-152,429
-64% -$41.6M 0.14% 206
2019
Q1
$68.1M Sell
237,162
-8,302
-3% -$2.4M 0.45% 58
2018
Q4
$64.5M Sell
245,464
-123
-0.1% -$33.8K 0.46% 61
2018
Q3
$67.3M Sell
245,587
-13,112
-5% -$3.4M 0.44% 58
2018
Q2
$61.6M Buy
258,699
+213,095
+467% +$49.3M 0.43% 65
2018
Q1
$10M Buy
45,604
+2,093
+5% +$492K 0.07% 318
2017
Q4
$9.79M Sell
43,511
-143
-0.3% -$30.5K 0.07% 297
2017
Q3
$8.29M Buy
43,654
+1,290
+3% +$246K 0.06% 302
2017
Q2
$7.97M Buy
42,364
+1,134
+3% +$204K 0.06% 313
2017
Q1
$6.82M Sell
41,230
-128
-0.3% -$20.4K 0.05% 329
2016
Q4
$5.95M Sell
41,358
-29,119
-41% -$3.9M 0.05% 323
2016
Q3
$8.83M Buy
70,477
+8,838
+14% +$1.14M 0.06% 289
2016
Q2
$8.1M Sell
61,639
-2,263
-4% -$310K 0.06% 290
2016
Q1
$8.88M Buy
63,902
+3,274
+5% +$438K 0.06% 277
2015
Q4
$8.45M Buy
60,628
+161
+0.3% +$22.2K 0.05% 282
2015
Q3
$8.46M Sell
60,467
-166
-0.3% -$24.9K 0.06% 279
2015
Q2
$9.95M Sell
60,633
-400
-0.7% -$63.9K 0.06% 264
2015
Q1
$9.42M Buy
61,033
+17,903
+42% +$2.55M 0.06% 274
2014
Q4
$5.42M Buy
43,130
+130
+0.3% +$16.1K 0.04% 336
2014
Q3
$5.14M Hold
43,000
0.03% 327
2014
Q2
$4.63M Hold
43,000
0.03% 341
2014
Q1
$4.28M Hold
43,000
0.03% 331
2013
Q4
$3.97M Hold
43,000
0.03% 343
2013
Q3
$3.6M Buy
43,000
+33,200
+339% +$2.85M 0.02% 342
2013
Q2
$802K Buy
+9,800
New +$733K 0.01% 475

Other funds holding ELV